{
    "clinical_study": {
        "@rank": "126121", 
        "arm_group": {
            "arm_group_label": "HCG is introduced with small catheter.", 
            "arm_group_type": "Experimental", 
            "description": "phase 1 non randomized pilot"
        }, 
        "brief_summary": {
            "textblock": "The endometrium is deprived of signals form the embryo in IVF conditions. Studies suggest\n      that placing HCG into the uterus prior to embryo transfer can enhance implantation."
        }, 
        "brief_title": "Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "The study is in pilot phase, uncontrolled. The risks appear to be minimal and there are\n      conflicting  new reports being announced.\n\n      A small amount of fluid with HCG is injected into the uterus. HCG is a potent signal to the\n      uterus for preparation for implantation.\n\n      This is not a funded study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - infertility patients undergoing IVF with good expectation of two embryos developing by\n        day 5. must speak and read English.\n\n        Exclusion Criteria:abnormal uterus\n\n        -"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "47 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01986374", 
            "org_study_id": "HCG 2013"
        }, 
        "intervention": {
            "arm_group_label": "HCG is introduced with small catheter.", 
            "description": "must have good blastocysts", 
            "intervention_name": "HCG is introduced", 
            "intervention_type": "Drug", 
            "other_name": "Improve results of IVF and embryo transfer"
        }, 
        "intervention_browse": {
            "mesh_term": "Chorionic Gonadotropin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "IVF , embryo implantation, HCG", 
        "lastchanged_date": "November 15, 2013", 
        "location": {
            "contact": {
                "email": "dawnc@ivfga.com", 
                "last_name": "Dawn Cook, MA", 
                "phone": "404-228-7199"
            }, 
            "facility": {
                "address": {
                    "city": "Atlanta", 
                    "country": "United States", 
                    "state": "Georgia", 
                    "zip": "30327"
                }, 
                "name": "Servy Massey Fertility Insititute"
            }, 
            "investigator": {
                "last_name": "Joe B Massey, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Intrauterine Injection of Human Chorionic Gonadotropin to Enhance Embryo Implantation", 
        "overall_contact": {
            "email": "drmassey@ivfga.com", 
            "last_name": "Joe B Massey, MD", 
            "phone": "4042287199"
        }, 
        "overall_contact_backup": {
            "email": "dawnc@ivfga.com", 
            "last_name": "Dawn Cooke, MA", 
            "phone": "4042287199"
        }, 
        "overall_official": {
            "affiliation": "Servy Massey Fertilty Institute", 
            "last_name": "Joe B Massey, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "compare pregnancy rates to established clinical norms.", 
            "measure": "HCG enhances pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "9 months."
        }, 
        "reference": {
            "PMID": "22047664", 
            "citation": "Mansour R, Tawab N, Kamal O, El-Faissal Y, Serour A, Aboulghar M, Serour G. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril. 2011 Dec;96(6):1370-1374.e1. doi: 10.1016/j.fertnstert.2011.09.044. Epub 2011 Nov 1."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01986374"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "compare implantation rate per embryo to clinical norms.", 
            "measure": "implantation rate", 
            "safety_issue": "No", 
            "time_frame": "9 months."
        }, 
        "source": "Servy Massey Fertility Insititute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Servy Massey Fertility Insititute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}